Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats

References

• PittB, KonstamMA. Overview of angiotensin II-receptor antagonists. Am J Cardiol. 1998;82(10A):47S–49S. doi:10.1016/S0002-9149(98)00807-89860359
   PubMed Web of Science ®Google Scholar
• StangierJ, SuCA, RothW. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients. J Int Med Res. 2000;28(4):149–167. doi:10.1177/14732300000280040111014323
   PubMed Web of Science ®Google Scholar
• SentjurcM, VrhovnikK, KristlJ. Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. J Control Release. 1999;59:87–97. doi:10.1016/S0168-3659(98)00181-310210725
   PubMed Web of Science ®Google Scholar
• TeaimaMH, YasserM, El-NabarawiMA, HelalDA. Proniosomal telmisartan tablets: formulation, in vitro evaluation and in vivo comparative pharmacokinetic study in rabbits. Drug Des Devel Ther. 2020;14:1319–1331. doi:10.2147/DDDT.S245013
   PubMed Web of Science ®Google Scholar
• YasserM, TeaimaM, El-NabarawiM, El-MonemRA. Cubosomal based oral tablet for controlled drug delivery of telmisartan: formulation, in-vitro evaluation and in-vivo comparative pharmacokinetic study in rabbits. Drug Dev Ind Pharm. 2019;45(6):981–994. doi:10.1080/03639045.2019.159039230865478
   PubMed Web of Science ®Google Scholar
• SivaramanA, BangaAK. Novel in situ forming hydrogel microneedles for transdermal drug delivery. Drug Deliv Transl Res. 2017;7(1):16–26. doi:10.1007/s13346-016-0328-527562294
   PubMed Web of Science ®Google Scholar
• ChenM, LiuX, FahrA. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: in vitro study with finite and infinite dosage application. Int J Pharm. 2011;408(1–2):223–234.21316430
   PubMed Web of Science ®Google Scholar
• AminS, SarfenejadA, AhmadJ, et al. Nanovesicular transfersomes for enhanced systemic delivery of telmisartan. Adv Sci Eng Med. 2013;5:299–308. doi:10.1166/asem.2013.1288
   Google Scholar
• TouitouE, GodinB, DayanN, WeissC, PiliponskyA, Levi-SchafferF. Intracellular delivery mediated by an ethosomal carrier. Biomaterials. 2001;22(22):3053–3059. doi:10.1016/S0142-9612(01)00052-711575480
   PubMed Web of Science ®Google Scholar
• Tuan-MahmoodTM, McCruddenMT, TorrisiBM, et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci. 2013;50(5):623–637. doi:10.1016/j.ejps.2013.05.00523680534
   PubMed Web of Science ®Google Scholar
• KumarV, BangaAK. Modulated iontophoretic delivery of small and large molecules through microchannels. Int J Pharm. 2012;434(1–2):106–114. doi:10.1016/j.ijpharm.2012.05.03022633929
   PubMed Web of Science ®Google Scholar
• TeaimaMH, MohamedMAA, Abd El RehemRT, et al. Enhanced transdermal delivery of bisoprolol hemifumarate via combined effect of iontophoresis and chemical enhancers: ex vivo permeation/in vivo pharmacokinetic studies. Pharmaceutics. 2021;13:682. doi:10.3390/pharmaceutics1305068234068544
   PubMed Web of Science ®Google Scholar
• LiGL, van der GeestR, ChanetL, van ZantenE, DanhofM, BouwstraJA. In vitro iontophoresis of R-apomorphine across human stratum corneum. Structure-transport relationship of penetration enhancement. J Control Release. 2002;84(1–2):49–57. doi:10.1016/S0168-3659(02)00259-612399167
   PubMed Web of Science ®Google Scholar
• AlbashR, AbdelbaryAA, RefaiH, El-NabarawiMA. Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation. Int J Nanomedicine. 2019;14:1953–1968. doi:10.2147/IJN.S19677130936696
   PubMed Web of Science ®Google Scholar
• RefaiH, HassanD, AbdelmonemR. Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate. Drug Deliv. 2017;24(1):278–288. doi:10.1080/10717544.2016.124792528165805
   PubMed Web of Science ®Google Scholar
• VaronaS, MartinA, CoceroMJ. Liposomal incorporation of lavandin essential oil by a thin-film hydration method and by particles from gas-saturated solutions. Ind Eng Chem Res. 2011;50(4):2088–2097. doi:10.1021/ie102016r
   Web of Science ®Google Scholar
• DimitrovDS, LiJ, AngelovaM, Jain, RK. Surface effects in preparation of cell-size liposomes. FEBS Lett. 1984;176(2):398–400. doi:10.1016/0014-5793(84)81205-3
   Web of Science ®Google Scholar
• BakheitAH, Abd-ElgalilAA, MustafaB, HaqueA, WaniTA. Telmisartan. Profiles Drug Subst Excip Relat Methodol. 2015;40:371–429.26051689
   PubMedGoogle Scholar
• AbdelmonemR, ElhabalSF, AbdelmalakNS, El-NabarawiMA, TeaimaMH. Formulation and characterization of acetazolamide/carvedilol niosomal gel for glaucoma treatment: in vitro, and in vivo study. Pharmaceutics. 2021;13:2. doi:10.3390/pharmaceutics13020221
   Web of Science ®Google Scholar
• AbdelbaryAA, Al-mahallawiAM, AbdelrahimME, AliAM. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration. Int J Nanomedicine. 2015;10:6339–6353. doi:10.2147/IJN.S9163126491298
   PubMed Web of Science ®Google Scholar
• AbdellatifMM, KhalilIA, KhalilMAF. Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: in-vitro, ex-vivo and in-vivo evaluation. Int J Pharm. 2017;527(1–2):1–11. doi:10.1016/j.ijpharm.2017.05.02928522423
   PubMed Web of Science ®Google Scholar
• TeaimaMH, AbdelhalimSA, El-NabarawiMA, AttiaDA, HelalDA. Non-ionic surfactant based vesicular drug delivery system for topical delivery of caffeine for treatment of cellulite: design, formulation, characterization, histological anti-cellulite activity, and pharmacokinetic evaluation. Drug Dev Ind Pharm. 2018;44(1):158–171. doi:10.1080/03639045.2017.138620628956468
   PubMed Web of Science ®Google Scholar
• YangSC, LuLF, CaiY, ZhuJB, LiangBW, YangCZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release. 1999;59(3):299–307. doi:10.1016/S0168-3659(99)00007-310332062
   PubMed Web of Science ®Google Scholar
• SafwatS, IshakRAH, HathoutRM, MortadaND. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity. Drug Dev Ind Pharm. 2017;43(7):1112–1125. doi:10.1080/03639045.2017.129368128276784
   PubMed Web of Science ®Google Scholar
• Al-MahallawiAM, KhowessahOM, ShoukriRA. Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm. 2014;472(1–2):304–314. doi:10.1016/j.ijpharm.2014.06.04124971692
   PubMed Web of Science ®Google Scholar
• MohammedMI, MakkyAM, TeaimaMH, AbdellatifMM, HamzawyMA, KhalilMA. Transdermal delivery of vancomycin hydrochloride using combination of nano-ethosomes and iontophoresis: in vitro and in vivo study. Drug Deliv. 2016;23(5):1558–1564.25726990
   PubMed Web of Science ®Google Scholar
• El-RidyMS, AbdelbaryA, EssamT, et al. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug Dev Ind Pharm. 2011;37:1491–1508. doi:10.3109/03639045.2011.58743121707323
   PubMed Web of Science ®Google Scholar
• GaurPK, MishraS, BajpaiM. Formulation and evaluation of controlled-release of telmisartan microspheres: in vitro/in vivo study. J Food Drug Anal. 2014;22(4):542–548. doi:10.1016/j.jfda.2014.05.00128911472
   PubMed Web of Science ®Google Scholar
• ZhangY, HuoM, ZhouJ, XieS. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed. 2010;99(3):306–314. doi:10.1016/j.cmpb.2010.01.00720176408
   PubMed Web of Science ®Google Scholar
• MendesAC, GorzelannyC, HalterN, SchneiderSW, ChronakisIS. Hybrid electrospun chitosan-phospholipids nanofibers for transdermal drug delivery. Int J Pharm. 2016;510(1):48–56. doi:10.1016/j.ijpharm.2016.06.01627286632
   PubMed Web of Science ®Google Scholar
• BhalariaMK, NaikS, MisraAN. Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exp Biol. 2009;47(5):368–375.19579803
   PubMed Web of Science ®Google Scholar
• DanaeiM, DehghankholdM, AtaeiS, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:57. doi:10.3390/pharmaceutics10020057
   PubMed Web of Science ®Google Scholar
• UchegbuIF, VyasSP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172:33–70. doi:10.1016/S0378-5173(98)00169-0
   Web of Science ®Google Scholar
• AburahmaMH. Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines. Drug Deliv. 2016;23(6):1847–1867.25390191
   PubMed Web of Science ®Google Scholar
• HaradaK, MurakamiT, KawasakiE, HigashiY, YamamotoS, YataN. In-vitro permeability to salicylic acid of human, rodent, and shed snake skin. J Pharm Pharmacol. 1993;45(5):414–418. doi:10.1111/j.2042-7158.1993.tb05567.x8099958
   PubMed Web of Science ®Google Scholar
• CaoY, ShiLL, CaoQR, YangM, CuiJH. In-vitro characterization and oral bioavailability of organic solvent-free solid dispersions containing telmisartan. Iran J Pharm Res. 2016;15(2):385–394.27642309
   PubMed Web of Science ®Google Scholar